Crystal Structures of the Complexes between Vancomycin and Cell-Wall Precursor Analogs

Journal of Molecular Biology

Volumn 385, Issue 5, 2009, Pages 1422-1432

  Nitanai, Yasushi ^a   Kikuchi, Takanori ^b   Kakoi, Kouji ^b   Hanamaki, Shinji ^b   Fujisawa, Ikuhide ^b   Aoki, Katsuyuki ^b  

^a Harima Institute ^*  (Japan)

^b TOYOHASHI UNIVERSITY OF TECHNOLOGY   (Japan)

Author keywords

cell wall precursor analog complexes; crystal structure; vancomycin; vancomycin resistant ligand; vancomycin sensitive ligand

Indexed keywords

LIGAND; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; CELL WALL; CRYSTAL STRUCTURE; DRUG STRUCTURE; ELECTRICITY; HYDROGEN BOND; LIGAND BINDING; PRECURSOR; PRIORITY JOURNAL; SUPRAMOLECULAR CHEMISTRY;

EID: 58649120796     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.10.026     Document Type: Article

References (53)

1. McCormick M.H., Stark W.M., Pittenger G.E., Pittenger R.C., and McGuire J.M. Vancomycin, a new antibiotic: I. Chemical and biologic properties. Antibiot. Annu. 1955-1956 (1956) 606-611
2. Geraci J.E., and Hermans P.E. Vancomycin. Mayo Clin. Proc. 58 (1983) 88-91
3. Levine J.F. Vancomycin: a review. Med. Clin. North Am. 71 (1987) 1135-1145
4. Perkins H.R. Specificity of combination between mucopeptide precursors and vancomycin or ristocetin. Biochem. J. 111 (1969) 195-205
5. Barna J.C.J., and Williams D.H. The structure and mode of action of glycopeptide antibiotics of the vancomycin group. Annu. Rev. Microbiol. 38 (1984) 339-357
6. Reynolds P.E. Structure, biochemistry, and mechanism of action of glycopeptide antibiotics. Eur. J. Microbiol. Infect. Dis. 8 (1989) 943-950
7. Uttley A.H., Collins C.H., Naidoo J., and George R.C. Vancomycin-resistant enterococci. Lancet 331 (1988) 57-58
8. Hiramatsu K., Aritaka N., Hanaki H., Kawasaki S., Hosoda Y., Hori S., et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350 (1997) 1670-1673
9. Walsh C.T. Vancomycin resistance-decoding the molecular logic. Science 261 (1993) 308-309
10. Walsh C.T., Fisher S.L., Park I.S., Prahalad M., and Wu Z. Bacterial resistance to vancomycin: five genes and one missing hydrogen bond tell the story. Chem. Biol. 3 (1996) 21-28
11. Bugg T.D.H., Wright G.D., Dutka-Malen S., Arthur M., Courvalin P., and Walsh C.T. Molecular basis for vancomycin resistance in Enterococcus faecium BM41 biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistant proteins VanH and VanA. Biochemistry 30 (1991) 10408-10415
12. Williams D.H., and Bardsley B. The vancomycin group of antibiotics and the fight against resistant bacteria. Angew. Chem. Int. Ed. 38 (1999) 1172-1193
13. Schäfer M., Schneider T.R., and Sheldrick G.M. Crystal structure of vancomycin. Structure 4 (1996) 1509-1515
14. Loll P.J., Bevivino A.E., Korty B.D., and Axelsen P.H. Simultaneous recognition of a carboxylate-containing ligand and an intramolecular surrogate ligand in the crystal structure of an asymmetric vancomycin dimer. J. Am. Chem. Soc. 119 (1997) 1516-1522
15. Loll P.J., Miller R., Weeks C.M., and Axelsen P.H. A ligand-mediated dimerization mode for vancomycin. Chem. Biol. 5 (1998) 293-298
16. Loll P.J., Kaplan J., Selinsky B.S., and Axelsen P.H. Vancomycin binding to low-affinity ligands: delineating a minimum set of interactions necessary for high-affinity binding. J. Med. Chem. 42 (1999) 4714-4719
17. 2+-vancomycin complex. J. Inorg. Biochem. 102 (2008) 936-942
18. Kaplan J., Korty B.D., Axelsen P.H., and Loll P.J. The role of sugar residues in molecular recognition by vancomycin. J. Med. Chem. 44 (2001) 1837-1840
19. Schäfer M., Pohl E., Schmidt-Bäse K., Scheldrick G.M., Hermann R., Malabarba A., et al. The molecular and crystal structure of the glycopeptide A-40926 aglycone. Helv. Chim. Acta 79 (1996) 1916-1924
20. Schäfer M., Scheldrick G.M., Schneider T.R., and Vértesy L. Structure of balhimycin and its complex with solvent molecules. Acta Crystallogr. Sect. D 54 (1998) 175-183
21. Lehmann C., Bunkóczi G., Vértesy L., and Scheldrick G.M. Structures of glycopeptide antibiotics with peptides that model bacterial cell-wall precursors. J. Mol. Biol. 318 (2002) 723-732
22. Scheldrick G.M., Paulus E., Vértesy L., and Hahn F. Structure of ureido-balhimycin. Acta Crystallogr. Sect. B 51 (1995) 89-98
23. Lehmann C., Debreczeni J.É., Bunkóczi C., Dauter M., Dauter Z., Vértesy L., and Sheldrick G.M. Structures of four crystal forms of decaplanin. Helv. Chim. Acta 86 (2003) 1478-1487
24. Scheldrick G.M., Jones P.G., Kennard O., Williams D.H., and Smith G.A. Structure of vancomycin and its complex with acetyl-d-adanyl-d-alanine. Nature 271 (1978) 223-225
25. Nagarajan R., Merkel K.E., Michel K.H., Haggins Jr. H.V., Hoehm M.M., Hunt A.H., et al. M43 antibiotics: methylated vancomycins and unrearranged CDP-I analogs. J. Am. Chem. Soc. 110 (1988) 7896-7897
26. Nitanai, Y., Kakoi, K. & Aoki, K. (2000). Crystal structure of the complex between vancomycin and a cell wall precursor analog, di-acetyl-Lys-d-Ala-d-Ala (PDB accession code 1FVM).
27. Williams D.H., Williamson M.P., Butcher D.W., and Hammond S.J. Detailed binding sites of the antibiotics vancomycin and ristocetin A: determination of intermolecular distances in antibiotic/substrate complexes by use of the time-dependent NOE. J. Am. Chem. Soc. 105 (1983) 1332-1339
28. Lee J.-G., Sagui C., and Roland C. Quantum simulations of the structure and binding of glycopeptide antibiotic aglycons to cell wall analogues. J. Phys. Chem. 109 (2005) 20588-20596
29. Williams D.H., Maguire A.J., Tsuzuki W., and Westwell M.S. An analysis of the origin of a cooperative binding energy of dimerization. Science 280 (1998) 711-714
30. Shiozawa H., Zerella R., Bardsley B., Tuck K.L., and Williams D.H. Noncovalent bond lengths and their cooperative shortening: dimers of vancomycin group antibiotics in crystals and in solution. Helv. Chim. Acta 86 (2003) 1359-1370
31. Mackay J.P., Gerhard U., Beauregard D.A., Westwell M.S., Searle M.S., and Williams D.H. Glycopeptide antibiotic activity and the possible role of dimerization: a model for biological signaling. J. Am. Chem. Soc. 116 (1994) 4581-4590
32. McPhail D., and Cooper A. Thermodynamics and kinetics of dissociation of ligand-induced dimers of vancomycin antibiotics. J. Chem. Soc. Faraday Trans. 93 (1997) 2283-2289
33. Nieto M., and Perkins H.R. Physicochemical properties of vancomycin and iodovancomycin and their complexes with diacetyl-l-lysyl-d-alanyl-d-alanine. Biochem. J. 123 (1971) 773-787
34. Rodriguez M.J., Snyder N.J., Zweifel M.J., Wilkie S.C., Stack D.R., Cooper R.D.G., et al. Novel glycopeptide antibiotics: N-alkylated derivatives active against vancomycin-resistant enterococci. J. Antibiot. 51 (1998) 560-569
35. Rao J., and Whitesides G.M. Tight binding of a dimeric derivative of vancomycin with dimeric l-Lys-d-Ala-d-Ala. J. Am. Chem. Soc. 119 (1997) 10286-10290
36. McPhail D., Cooper A., and Freer A. Crystallization and preliminary X-ray crystallographic analysis of a vancomycin-N-acetyl-d-Ala-d-Ala complex. Acta Crystallogr. Sect. D 55 (1999) 534-535
37. Cristofaro M.F., Beauregard D.A., Yan H., Osborn N.J., and Williams D.H. Cooperativity between non-polar and ionic forces in the binding of bacterial cell wall analogues by vancomycin in aqueous solution. J. Antibiot. 48 (1995) 805-810
38. Nagarajan R. Antibacterial activities and modes of action of vancomycin and related glycopeptides. Antimicrob. Agents Chemother. 35 (1991) 605-609
39. Sundram U.N., Griffin J.H., and Nicas T.I. Novel vancomycin dimers with activity against vancomycin-resistant enterococci. J. Am. Chem. Soc. 118 (1996) 13107-13108
40. Staroske T., and Williams D.H. Synthesis of covalent head-to-tail dimers of vancomycin. Tetrahedron Lett. 39 (1998) 4917-4920
41. Adamczyk M., Moore J.A., Rege S.D., and Yu Z. Investigations into self-association of vancomycin covalent dimers using surface plasmon resonance technology. Bioorg. Med. Chem. Lett. 9 (1999) 2437-2440
42. Lu J., Yoshida O., Hayashi S., and Arimoto H. Synthesis of rigidly-linked vancomycin dimers and their in vivo efficacy against resistant bacteria. Chem. Commun. (2007) 251-253
43. Rao J., Lahiri J., Isaacs L., Weis R.M., and Whitesides G.M. A trivalent system from vancomycin-d-Ala-d-Ala with higher affinity than avidin-biotin. Science 280 (1988) 708-711
44. Arimoto H., Nishimura K., Hayakawa I., Kinumi T., and Uemura D. Multi-valent polymer of vancomycin: enhanced antibacterial activity against VRE. Chem. Commun. 15 (1999) 1361-1362
45. Satow Y., Mikuni A., Kamiya N., and Ando M. Focusing X-ray beamline for macromolecular crystallography at the Photon Factory. Rev. Sci. Instrum. 60 (1989) 2394-2396
46. Leslie A.G.W. Molecular data processing. In: Moras D., Podjarny A.D., and Thierry J.C. (Eds). Crystallographic Computing (1990), Oxford University Press, Oxford, UK 50-61
47. Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. Sect. D 50 (1994) 760-763
48. Navaza J. AMoRe: an automated package for molecular replacement. Acta Crystallogr. Sect. A 50 (1994) 157-163
49. Tong L. Combined molecular replacement. Acta Crystallogr. Sect. A 52 (1996) 782-784
50. Brünger A.T., Kuriyan J., and Karplus M. Crystallographic R factor refinement by molecular dynamics. Science 235 (1987) 458-460
51. Kleywegt G., and Jones T. Databases in protein crystallography. Acta Crystallogr. Sect. D 54 (1998) 1119-1131
52. McRee D.E. XtalView/Xfit-a versatile program for manipulating atomic coordinates and electron density. J. Struct. Biol. 125 (1999) 156-165
53. Scheldrick G.M., and Schneider T.R. SHELXL: high resolution refinement. Methods Enzymol. 277 (1997) 319-343